Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Qiagen Acquires Diagnostics Firm

June 11, 2007 | A version of this story appeared in Volume 85, Issue 24

Qiagen, a Dutch supplier of samples and assays for biotechnology research, will acquire Maryland-based Digene in a stock and cash deal valued at about $1.6 billion. Qiagen provides assay technologies for biological targets such as DNA, RNA, and proteins. It will obtain Diagene's diagnostic technology for screening human papillomavirus, the only HPV screening technology approved in the U.S. and Europe.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.